Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
País/Região como assunto
País de afiliação
Intervalo de ano de publicação
1.
Pathol Biol (Paris) ; 63(3): 136-43, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25845294

RESUMO

Hemolytic uremic syndrome is a rare disease, frequently responsible for renal insufficiency in children. Recent findings have led to renewed interest in this pathology. The discovery of new gene mutations in the atypical form of HUS and the experimental data suggesting the involvement of the complement pathway in the typical form, open new perspectives for treatment. This review summarizes the current state of knowledge on both typical and atypical hemolytic uremic syndrome pathophysiology and examines new perspectives for treatment.


Assuntos
Síndrome Hemolítico-Urêmica/fisiopatologia , Animais , Antibacterianos/uso terapêutico , Anticorpos Monoclonais Humanizados/uso terapêutico , Infecções Bacterianas/complicações , Toxinas Bacterianas/efeitos adversos , Ensaios Clínicos como Assunto , Proteínas do Sistema Complemento/fisiologia , Modelos Animais de Doenças , Avaliação Pré-Clínica de Medicamentos , Infecções por Escherichia coli/complicações , Infecções por Escherichia coli/microbiologia , Previsões , Predisposição Genética para Doença , Síndrome Hemolítico-Urêmica/classificação , Síndrome Hemolítico-Urêmica/etiologia , Síndrome Hemolítico-Urêmica/genética , Síndrome Hemolítico-Urêmica/microbiologia , Síndrome Hemolítico-Urêmica/terapia , Humanos , Transplante de Rim , Transplante de Fígado , Camundongos , Papio , Plasma , Substitutos do Plasma , Toxina Shiga/efeitos adversos , Escherichia coli Shiga Toxigênica/imunologia , Escherichia coli Shiga Toxigênica/patogenicidade , Trombofilia/etiologia , Fator A de Crescimento do Endotélio Vascular/uso terapêutico
2.
J Environ Radioact ; 118: 1-8, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23220539

RESUMO

The aim of the present work was to compare the results obtained with gross alpha methods such as evaporation, co-precipitation and total evaporation by liquid scintillation counting and to check whether these results are representative of the real total alpha activity concentration on the sample. The study was carried out on eight natural waters with very different radioactive characteristics. For all the samples uranium ((238)U, (235)U, and (234)U), radium ((226)Ra and (224)Ra), (210)Po, and (232)Th isotopes were also assayed by using radiochemical separation and alpha spectrometry in order to determine the sum of the activities of these alpha emitters. Precision (expressed as relative standard deviation) was below 28% for evaporation and below 18% for co-precipitation. In the case of total by liquid scintillation counting it was below 10% for samples with Total Alpha activity above 0.1 Bq/L (this value is about three times the MDA). Furthermore, for most of the studied waters, the Total Alpha activity and the gross alpha activity determined by the three methods were comparable. The obtained bias by the evaporation, co-precipitation, and total evaporation by liquid scintillation counting methods was lower than 40%, 25% and 20%, respectively. The ANOVA test was applied to find out if there was significant variability among the methods. For the samples with the most common radiochemical characteristics there were no significant differences among the three studied methods. However differences were detected for samples with a high saline content or with a very low activity level.


Assuntos
Poluentes Radioativos da Água/análise , Rádio (Elemento)/análise , Contagem de Cintilação , Análise Espectral , Urânio/análise
3.
Chemosphere ; 78(10): 1256-62, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20092867

RESUMO

During the last years, consumption of health supplements has increased in our society. They are recommended as an additional source of minerals, vitamins, omega-3 and omega-6 fatty acids, in the diet. A lot of these supplements contain oils among their components (fish oils or vegetable oils), especially those recommended for their omega-3 content. Due to their persistence and lipophilic characteristics, polychlorinated dibenzo-p-dioxins (PCDDs), polychlorinated dibenzofurans (PCDFs), dioxin-like polychlorinated biphenyls (PCBs), marker PCBs, and polybrominated diphenyl ethers (PBDEs) bioaccumulate in fat tissues, especially in those animals, as fish, which show low metabolic capability. Therefore, the consumption of nutritional supplements with oil components can increase the intake of persistent organic pollutants (POPs) through the diet. The aim of this study was to analyse 15 of these supplements commercialized in Spain to determinate their POPs concentrations and their intake for their consumers. Concentrations of POPs in the dietary supplements studied (PCDD/Fs: 0.04-2.4 pg TEQ g(-1); dl-PCBs: 0.01-12.1 pg TEQ g(-1); marker PCBs: 0.17-116 ng g(-1); and PBDEs: 0.07-18.2 ng g(-1)) were in the low-medium range of those reported in literature for other countries. Vegetable oil and mineral-based supplements showed concentrations of POPs clearly lower than those based on fish oil. Among these, those based on cod liver oil presented the highest concentrations detected in the study, exceeding the maximum levels established in European regulations for marine oils for human consumption. In general, the intake of POPs via the consumption of these supplements would be lower than the intake derived from fish consumption.


Assuntos
Benzofuranos/análise , Suplementos Nutricionais/análise , Poluentes Ambientais/análise , Éteres Difenil Halogenados/análise , Bifenilos Policlorados/análise , Dibenzodioxinas Policloradas/análogos & derivados , Polímeros/análise , Óleo de Fígado de Bacalhau/química , Ácidos Graxos Ômega-3/química , Dibenzodioxinas Policloradas/análise , Espanha , Vitaminas/química
4.
Heart Lung ; 20(4): 409-13, 1991 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-1906447

RESUMO

Diarrhea is a significant complication for the patient being tube-fed. The purpose of this study was to observe whether giving a bulk-forming cathartic to patients receiving enteral nutrition via nasogastric or nasoduodenal tube would result in firmer stools for these patients. Forty-nine patients in a large medical center were randomly assigned to either a control or an experimental group. During the 6-day study period 1 teaspoon (5 ml) of psyllium preparation was administered through the feeding tube three times a day. Data were analyzed by using the Mann-Whitney U test for nonparametric data. The hypothesis that giving a bulk-forming cathartic would lead to firmer stools was supported at an alpha level of less than 0.01. The results of this study suggest that use of a bulk-forming cathartic in tube-fed patients will significantly reduce the diarrhea associated with this type of feeding.


Assuntos
Diarreia/tratamento farmacológico , Nutrição Enteral/efeitos adversos , Psyllium/uso terapêutico , Administração Oral , Antibacterianos/efeitos adversos , Diarreia/etiologia , Nutrição Enteral/enfermagem , Microbiologia de Alimentos , Humanos , Intolerância à Lactose/complicações , Pessoa de Meia-Idade , Concentração Osmolar , Psyllium/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA